DURECT CORP: Nasdaq/NYSE listing notice — DURECT receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period.

DURECT CORP

Nasdaq notified DURECT on Jan 9, 2025 that bid price below $1.00 for 30 consecutive days violates Minimum Bid Price Requirement.
Company has until July 8, 2025 to regain compliance; must close at ≥$1.00 for 10 consecutive days.
If not cured by July 8, Nasdaq may grant a second 180-day period if other listing standards met.
Company will monitor bid price and consider available options to resolve deficiency.
Failure to cure could lead to delisting; company may appeal to Nasdaq hearings panel.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

DURECT CORP received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

January 9, 2025, DURECT Corporation, a Delaware Corporation (the “Company”), received a letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) informing the Company that, b

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-25-004522

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.